058530 — Panacea Income Statement

0.000.00%

Last trade - 00:00

TechnologyMicro Cap

Annual income statement for Panacea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41,111	20,059	13,730	14,330	21,960
Cost of Revenue
Gross Profit	16,864	13,387	3,940	4,112	4,672
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	39,718	19,076	16,202	14,508	31,283
Operating Profit	1,393	983	-2,473	-178	-9,323
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-27,384	-6,170	-1,961	415	-8,475
Provision for Income Taxes
Net Income After Taxes	-27,495	-6,671	-1,753	1,350	-7,945
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-27,495	-6,671	-656	-916	-9,590
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-27,495	-6,671	-656	-916	-9,590
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3,613	-620	-87	74.7	-167
Dividends per Share